CD39 in the development and progression of pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a devastating progressive disease characterised by pulmonary arterial vasoconstriction and vascular remodelling. Endothelial dysfunction has emerged as a contributing factor in the development of PAH. However, despite progress in the understanding of the path...

Descripción completa

Detalles Bibliográficos
Autores principales: Willcox, Abbey, Lee, Natasha Ting, Nandurkar, Harshal H., Sashindranath, Maithili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832216/
https://www.ncbi.nlm.nih.gov/pubmed/35947229
http://dx.doi.org/10.1007/s11302-022-09889-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832216/
https://www.ncbi.nlm.nih.gov/pubmed/35947229
http://dx.doi.org/10.1007/s11302-022-09889-9

Ejemplares similares